I have not engaged in negotiations with drug companies regarding the provision of anti-cancer drugs. The Health Service Executive regularly negotiates with drug companies seeking to have their products placed on the list of reimbursable products. This is a regular and ongoing practice.
I can also confirm that officials in the Department and the Health Service Executive are in ongoing contact with the Irish Pharmaceutical Healthcare Association regarding a new pricing agreement for originator drugs. The previous agreement expired on 1st March 2012 with an understanding that the existing arrangements would apply until such time as a new agreement is reached.
Question No. 197 answered with Question No. 174.